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Objectives: We	 investigated	 the	 use	 of	 RSV‐specific	 ICD‐10	 codes	 for	 RSV	
surveillance.
Methods: We	performed	a	 retrospective	descriptive	data	 analysis	based	on	exist‐
ing	ICD‐10‐based	surveillance	systems	for	ALRI	in	primary	and	secondary	care	and	
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lance	practice,	compared	 to	 the	 traditional	 surveillance.	 It	 can	not	
only	describe	epidemiology	of	disease,	but	also	capture	and	transmit	
data	 rapidly	 in	a	 standardized	and	sustainable	way	at	 lower	costs,	
and	provide	very	early	warning	of	potential	public	health	threats.10‐12
The	Robert	Koch	Institute	(RKI)	established	the	10th	revision	of	ICD	












tification	 of	 laboratory‐confirmed	 influenza	 have	 shown	 mixed	
results.14,16‐18	So	 far,	 few	studies	have	 looked	at	accuracy	of	RSV‐










systems	 SEEDARE	 and	 ICOSARI,	 and	 from	 the	 virological	 surveil‐






The	 SEEDARE	 system	 was	 approved	 by	 the	 German	 Federal	
Commissioner	for	Data	Protection	and	Freedom	of	Information,	and	




activities	 were	 approved	 by	 the	 German	 Federal	 Commissioner	














We	 estimated	 number	 of	 RSV‐ICD‐cases	 and	 confirmed‐RSV‐
cases	 by	 gender,	 age	 group	 (0‐1,	 2‐4,	 5‐14,	 15‐34,	 35‐49,	 50‐59,	
≥60	years),	and	calendar	week	based	on	each	data	source,	respectively.





evaluation.	We	 calculated	 sensitivity	 of	 RSV‐specific	 ICD‐10	 code	
diagnosis	 as	 proportion	 of	 RSV‐ICD‐cases	 among	 confirmed‐RSV‐
cases,	 and	 specificity	 as	 proportion	of	 non‐RSV‐ICD‐cases	 among	
non‐confirmed‐RSV‐cases	of	the	identified	practices.	We	calculated	
sensitivity	 and	 specificity	 of	 RSV‐specific	 ICD‐10	 code	 diagnosis	
among	young	children,	in	RSV	seasons,	and	combined	with	different	
general	ARI	 ICD‐10	codes	J06.‐	acute	upper	respiratory	 infections	
of	 multiple	 and	 unspecified	 sites	 (J06,	 J06.0,	 J06.8,	 J06.9),	 J11.‐	
influenza,	 virus	 not	 identified	 (J11,	 J11.0,	 J11.1,	 J11.8),	 J12.‐	 viral	
pneumonia,	not	elsewhere	classified	(J12,	J12.8,	J12.9),	J18.‐	pneu‐
monia,	 organism	unspecified	 (J18,	 J18.0,	 J18.8,	 J18.9),	 J20.‐	 acute	















diagnosed	 with	 J12.1,	 432	 (37%)	 with	 J20.5,	 and	 395	 (34%)	 with	
J21.0.	 The	proportion	of	RSV‐ICD‐cases	 among	 all	ARI‐ICD‐cases	
was	0.1%.





The	 cumulative	number	 (88)	 of	 the	RSV‐ICD‐cases	within	 the	
observed	 10‐year	 period	 peaked	 in	 the	 8th	 calendar	 week,	 and	
the	proportion	 (0.3%)	of	RSV‐ICD‐cases	among	all	ARI‐ICD‐cases	
peaked	 in	 the	 2nd	 calendar	 week.	 The	 RSV	 season	 on	 average	
was	 from	 41st	 to	 16th	 calendar	week	with	 the	 season	 length	 of	
28	 weeks.	 Within	 the	 RSV	 seasons,	 92%	 (1075)	 RSV‐ICD‐cases	
were	captured.
3.1.2 | Descriptive analysis of confirmed‐RSV‐cases 
based on virological surveillance data
From	week	40/2010‐18/2017,	1785	 (8%)	 respiratory	specimens	of	
ARI	or	influenza‐like	illness	(ILI)	patients	were	RSV	positive.
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3.2 | Integration of RSV data of practices 
participated in SEEDARE and virological surveillance
Forty‐eight	sentinel	practices	participated	in	both	SEEDARE	and	the	
virological	surveillance	from	week	40/2010‐13/2017.	In	total,	5589	
respiratory	 specimens	 of	 the	 48	 practices	 were	 tested	 for	 RSV.	
Of	 those,	 400	 (7%)	 were	 RSV	 positive,	 and	 2624	 (47%)	 could	 be	
matched	with	 the	medical	 consultations	based	on	SEEDARE	one	 to	
one	(Figure	3).
Overall,	 the	 sensitivity	 of	 RSV‐specific	 ICD‐10	 code	 diagnosis	
was	6%	(95%‐CI:	3%‐12%),	and	the	specificity	was	99.8%	(95%‐CI:	
99.6%‐99.9%).	 The	 sensitivity	 (16%,	 95%‐CI:	 7%‐29%)	 increased	
among	 children	 aged	<5	 years	 and	 during	 the	RSV	 seasons	 based	
on	 the	 virological	 data	 (48th–15th	 calendar	week),	 and	 the	 speci‐
ficity	 (99.5%,	95‐CI:	97.5%‐99.9%)	 remained	high.	 In	 children	aged	
<5	 years	 and	 in	 RSV	 seasons,	 the	 sensitivities	 of	 RSV‐specific	
ICD‐10	codes	combined	with	general	ALRI	ICD‐10	codes	J18.‐,	J20.‐,	











3.3.1 | Descriptive analysis of RSV‐ICD‐cases based 
on ICOSARI data
Among	1	417	700	 respiratory	disease,	hospitalizations	 from	week	
01/2009‐15/2017,	 7345	 (0.5%)	 were	 hospitalizations	 with	 any	 of	
the	RSV‐specific	 ICD‐10	 codes	 as	primary	or	 secondary	discharge	
diagnosis,	and	3154	(0.2%)	as	admission	diagnosis.	Of	the	7345	RSV	
hospitalizations,	6918	 (94%)	were	with	RSV‐specific	 ICD‐10	codes	
as	 primary	 discharge	 diagnosis.	 Of	 the	 three	 RSV‐specific	 ICD‐10	
codes,	 J21.0	was	most	 frequently	 diagnosed	 as	 primary	discharge	
(2705;	39%)	and	also	admission	diagnosis	(1679;	53%).
Of	 the	 6918	 RSV‐ICD‐cases,	 93%	 (6415)	 were	 children	 aged	






The	 cumulative	number	 (535)	of	RSV‐ICD‐cases	peaked	 in	 the	

































codes,	 J21.0	 (acute	bronchiolitis	due	 to	RSV)	was	most	 frequently	
diagnosed	 in	 secondary	 care	 based	 on	 ICOSARI	 and	 J20.5	 (acute	
bronchitis	due	to	RSV)	in	primary	care	based	on	SEEDARE.
Based	on	the	three	data	sources,	the	RSV	season	onset	ranged	
from	 mid‐October	 to	 end‐November,	 the	 season	 offset	 was	 in	
mid‐April,	 and	 the	 peak	 of	 season	 ranged	 from	 end‐January	 to	
mid‐February	 in	Germany.	The	RSV	season	 length	ranged	from	20	
to	 28	 weeks.	 The	 RSV	 seasons	 captured	 most	 of	 the	 RSV	 cases.	
RSV	season	onset,	offset,	peak	week,	and	season	 length	based	on	
ICOSARI	and	virological	surveillance	were	similar.	Based	on	SEEDARE 
outpatient	 surveillance,	 the	 season	 began	 earlier.	 The	 outpatient	
syndromic	surveillance	may	provide	earlier	warning	of	RSV	spread	
compared	to	the	ICOSARI	inpatient	syndromic	surveillance	and	the	












We	 found	 that	 RSV‐specific	 ICD‐10	 codes	were	 less	 sensitive	























general	 ARI	 ICD‐10	 codes.	 RSV‐specific	 ICD‐10	 codes	 combined	
with	two	groups	of	general	ALRI	ICD‐10	codes	achieved	moderate	
sensitives	and	high	specificities.	The	high	sensitivity	of	RSV‐specific	






% 95%‐CI % 95%‐CI
RSV	codesa 6 3‐12 99.8 99.6‐99.9
<2 y of age
RSV	codes 8 2‐22 99.4 95.6‐99.9
<5 y of age
RSV	codes 14 6‐26 99.6 98‐99.9
In RSV seasonsb
RSV	codes 7 3‐12 99.8 99.5‐99.9
<5 y of age and in RSV seasons
RSV	codes 16 7‐29 99.5 98‐99.5
RSV	codes	+	J06.‐c 48 34‐63 62 55‐68
RSV	codes	+	J11.‐d 30 18‐45 75 68‐80
RSV	codes	+	J12.‐e 16 7‐29 99.5 98‐99.9
RSV	codes	+	J18.‐f 30 18‐45 98 95‐99
RSV	codes	+	J20.‐g 30 18‐45 92 88‐95
RSV	codes	+	J21.‐h 16 7‐29 99.5 98‐99.9
RSV	codes	+	J22 16 7‐29 99 97‐99.9
RSV	codes	+	B34.9 28 16‐42 80 74‐85
RSV	codes	+	J18.‐,	J20.‐ 44 30‐59 91 86‐94
RSV	codes	+	J18.‐,	J20.‐,	
B34.9
56 41‐70 72 65‐77
RSV	codes	+	J11.‐,	J18.‐,	
J20.‐,	B34.9
62 47‐75 48 42‐55
RSV	codes	+	J12.‐,	J18.‐,	
J20.‐,	J21.‐,	J22
44 30‐59 90 85‐94
RSV	codes	+	all	general	
ARI	codesi












6  |     CAI et Al.


























































27 29 31 33 35 37 39 41 43 45 47 49 51 1 3 5 7 9 11 13 15 17 19 21 23 25









17 7 2 3 17
2792
212





















     |  7CAI et Al.
ICD‐10	codes	combined	with	all	general	ARI	ICD‐10	codes	suggests	
that	in	addition	to	RSV‐specific	ICD‐10	codes,	most	laboratory‐con‐
firmed	 RSV	 infections	 were	 diagnosed	 with	 general	 ARI	 ICD‐10	
codes.	 Thus,	 the	misclassification	 related	 to	 inaccurate	 labeling	of	
RSV	 infections	 with	 other	 disease‐	 or	 pathogen‐specific	 ICD‐10	
codes	was	uncommon	in	the	present	study.
The	 present	 study	 has	 some	 limitations.	 The	 sensitivity	 and	
specificity	 of	 RSV‐specific	 ICD‐10	 code	 diagnoses	 in	 secondary	
care	could	not	be	evaluated	on	a	case	by	case	basis	since	virolog‐


































The	use	of	RSV‐specific	 ICD‐10	 code	data	may	be	 a	useful	 indi‐











and	 high	 specificities,	 respectively.	 Thus,	 when	 establishing	 an	
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